Document is current

Article History

Received: 2 February 2025

Accepted: 4 July 2025

First Online: 19 July 2025

Declarations

:

: Institutional Review Board (IRB) approval included that for all research involving human subjects, freely-given written informed consent to participate in the study and written consent to publish would be obtained from participants and that for children under the age of 18, their parent or legal guardian provided written consent and that the child provided assent to participate and to publish. After receiving IRB approval (Heartland IRB file number HIRB Project No. 10052023-515; Clinical Trial Number—not applicable) the review of the above referenced protocol was conducted in accordance with the ethical principles of the Belmont Report. Throughout, the research was carried out following the guidelines of the ethics committees listed in this statement and written informed consent for participation and publication was obtained from those who involved in the current study.

: The IRB approvals included specific consent to participate for all participants over the age of 18 years and that for children under the age of 18, their parent or legal guardian provided written consent and that the child also provided assent to participate.

: The IRB approvals included specific consent for data publication for all participants over the age of 18 years and that for children under the age of 18, their parent or legal guardian provided written consent and that the child also provided assent for data publication.

: The authors declare no competing interests.